Takuya Tsunoda

Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies

Andrea L.A. Wong, Ross A. Soo, Daniel S.W. Tan et al. · Annals of Oncology · 2015 · 166 citations

Refractory Solid Malignancies, Medicine, Cancer Biology +8

Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens

Koji Kono, Hisae Iinuma, Yasunori Akutsu et al. · Journal of Translational Medicine · 2012 · 142 citations · Full text

Vaccination with multiple peptides derived from novel cancer‐testis antigens can induce specific T‐cell responses and clinical responses in advanced esophageal cancer

Koji Kono, Yoshiki Mizukami, Yataro Daigo et al. · Cancer Science · 2009 · 136 citations · Full text

Identification of human leukocyte antigen‐A24‐restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy

Takako Suda, Takuya Tsunoda, Yataro Daigo et al. · Cancer Science · 2007 · 120 citations · Full text

Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer

Motoki Miyazawa, R. Ohsawa, Takuya Tsunoda et al. · Cancer Science · 2009 · 117 citations · Full text